Dopamine transporters decrease with age
- PMID: 8691238
Dopamine transporters decrease with age
Abstract
Postmortem studies have documented degeneration of dopamine cells with age, but the changes that occur in healthy aging individuals is less clear. The purpose of this study was to evaluate the extent to which age-induced changes in dopamine transporters occur in subjects with no evidence of motor impairment.
Methods: We evaluated 23 right-handed healthy volunteers (age range 20-74 yr) using PET and [11C]d-threo-methylphenidate. The ratio of the distribution volume for [11C]d-threo-methylphenidate in striatum to that in cerebellum was used as model parameter for dopamine transporter availability (Bmax/Kd + 1).
Results: Dopamine transporter availability was significantly lower in subjects > 40 yr of age than in those < 40 yr. Estimates of dopamine transporter availability showed a significant negative correlation with age both for the putamen (r = -0.72, p < 0.0001) and the caudate (r = -0.74, p < 0.0001). Dopamine transporter availability was higher in the left than in the right putamen but did not differ between the left and right caudate.
Conclusion: This study documents a 6.6% decrease per decade of life in striatal dopamine transporters of healthy volunteers.
Similar articles
-
A new PET ligand for the dopamine transporter: studies in the human brain.J Nucl Med. 1995 Dec;36(12):2162-8. J Nucl Med. 1995. PMID: 8523098
-
Carbon-11-d-threo-methylphenidate binding to dopamine transporter in baboon brain.J Nucl Med. 1995 Dec;36(12):2298-305. J Nucl Med. 1995. PMID: 8523123
-
Decreased dopamine transporters with age in health human subjects.Ann Neurol. 1994 Aug;36(2):237-9. doi: 10.1002/ana.410360218. Ann Neurol. 1994. PMID: 8053661
-
[(11)]Cocaine: PET studies of cocaine pharmacokinetics, dopamine transporter availability and dopamine transporter occupancy.Nucl Med Biol. 2001 Jul;28(5):561-72. doi: 10.1016/s0969-8051(01)00211-6. Nucl Med Biol. 2001. PMID: 11516700 Review.
-
Development of imaging agents for the dopamine transporter.Med Res Rev. 1995 Sep;15(5):419-44. doi: 10.1002/med.2610150503. Med Res Rev. 1995. PMID: 8531503 Review. No abstract available.
Cited by
-
Age-associated striatal dopaminergic denervation and falls in community-dwelling subjects.J Rehabil Res Dev. 2009;46(8):1045-52. doi: 10.1682/jrrd.2009.03.0030. J Rehabil Res Dev. 2009. PMID: 20157861 Free PMC article.
-
Catechol-O-methyltransferase valine(158)methionine polymorphism modulates brain networks underlying working memory across adulthood.Biol Psychiatry. 2009 Sep 15;66(6):540-8. doi: 10.1016/j.biopsych.2009.04.014. Epub 2009 Jun 17. Biol Psychiatry. 2009. PMID: 19539269 Free PMC article.
-
Asymmetries of the subthalamic activity in Parkinson's disease: phase-amplitude coupling among local field potentials.Brain Commun. 2024 Jun 11;6(3):fcae201. doi: 10.1093/braincomms/fcae201. eCollection 2024. Brain Commun. 2024. PMID: 38894949 Free PMC article.
-
_targeting dopamine transporter to ameliorate cognitive deficits in Alzheimer's disease.Front Cell Neurosci. 2023 Nov 13;17:1292858. doi: 10.3389/fncel.2023.1292858. eCollection 2023. Front Cell Neurosci. 2023. PMID: 38026688 Free PMC article. Review.
-
Arousal, interindividual differences and temporal binding a psychophysiological study.Psychol Res. 2024 Jul;88(5):1653-1677. doi: 10.1007/s00426-024-01976-3. Epub 2024 May 28. Psychol Res. 2024. PMID: 38806732 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
